Bio-Thera Solutions, Ltd. (SHSE: 688177)
Health Care · Biotechnology · CN
CN¥21.03
+0.96% today · -25.5% 1Y
Bio-Thera Solutions, Ltd. (SHSE: 688177) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.30B.
Over the last twelve months the share price has lost 25.5%, trading between 15.57 and 29.28.
Tweenvest scores Bio-Thera Solutions, Ltd. across four factors: quality 49/100, value 61/100, growth 100/100. Its strongest factor is growth.
688177 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.30B
- Revenue (TTM)
- $148.96M
- P/E
- —
- EPS
- -1.11
- Dividend yield
- —
- Beta (5Y)
- 0.39
- 52-week high
- CN¥29.28
- 52-week low
- CN¥15.57
- Avg volume (3M)
- —
- Shares outstanding
- 414.08M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AnaptysBio, Inc.NasdaqGS: ANAB | $1.36B | $46.21 | +1.23% |
| Pharma Mar, S.A.BME: PHM | $1.33B | €68.60 | -1.65% |
| Vcanbio Cell & Gene Engineering Corp., LtdSHSE: 600645 | $1.32B | CN¥19.41 | +3.58% |
| Vitrolife AB (publ)OM: VITR | $1.30B | Skr93.10 | -3.32% |
| Liaoning Chengda Biotechnology Co., Ltd.SHSE: 688739 | $1.29B | CN¥21.02 | +1.94% |
| Everest Medicines LimitedSEHK: 1952 | $1.28B | HK$28.64 | +3.39% |
| Damora Therapeutics, Inc.NasdaqCM: DMRA | $1.27B | $20.56 | -0.44% |
| Nanobiotix S.A.ENXTPA: NANO | $1.27B | €22.34 | -0.89% |
Figures last refreshed Oct 4, 2026.